United Kingdom· GB-APID-28795711000001102
Aripiprazole 30mg tablets
A aripiprazole product containing aripiprazole, registered in United Kingdom by Actavis UK Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Aripiprazole is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AX12 (aripiprazole), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Aripiprazole · ATC N05AX12
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aripiprazole costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in United States to $3.12 in Switzerland — a ×21 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Aripiprazole · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.12
- IT Italy$1.19
- FR France$1.06
- US United States$0.15 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Aripiprazole
- Manufacturer
- Actavis UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N05AX12
- ATC class
- Aripiprazole
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5012617025326
- gtin05012617025326
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
468 interactions on record for aripiprazole.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aripiprazole · interactions on record
468 records
- 11 severe
- 339 moderate
- 2 minor
- 67 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
- FamotidineA02BA03moderate
49 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aripiprazole in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABILIFYOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- United StatesABILIFYOtsuka America Pharmaceutical, Inc.
- SpainABIK 30 MG COMPRIMIDOS EFGKern Pharma S.L.
- PolandAbilifyOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsAbilify 30 mg, tablettenOtsuka Pharmaceutical Netherlands B.V.
- FinlandAbilifyOtsuka Pharmaceutical Netherlands B.V.
- CanadaABILIFYOTSUKA PHARMACEUTICAL CO LTD
- SwedenAbilify 30 mg Munsönderfallande tablettOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · 300 Mg, Arileto
- Belgium · Aripiprazol Krka, Aripiprazol Sandoz
- Bulgaria · Абизол, Арикоган
- Cyprus · Aripiprazole Aurobindo, Aripiprazole Krka
- Czechia · Abyca, Aricogan
- Germany · Aripipan, Aripiprazol 1 A Pharma
- Denmark · Aripiprazol Krka, Aripiprazol Stada
- Estonia · Aregzilap, Aripiprazole Stada
- Spain · Abik, Abilium
- Finland · Aripiprazol Krka, Aripiprazol Stada
- France · Aripiprazole Almus, Aripiprazole Arrow
- Greece · Abelfiz, Aripility
- Croatia · Aregzilap, Aripiprazol Pliva
- Hungary · Aripiprazol Sandoz, Aripiprazol Stada
- Ireland · Aripiprazole Brillpharma (Ireland), Aripiprazole Clonmel
- Iceland · Abilify, Abilify Maintena
- Italy · Aberipra, Aripiprazolo Alter
- Liechtenstein · Abilify, Abilify Maintena
- Lithuania · Aregzilap, Aripiprazole Stada
- Luxembourg · Aripiprazol Ratiopharm, Aripiprazole Eg
- Latvia · Aregzilap, Aripiprazole Acino
- Malta · Aripiprazol Generis, Aripiprazole Ascend
- Netherlands · Aribit Odt, Aricogan
- Norway · Abilify, Abilify Maintena
- Poland · Abilium, Apiprax
- Portugal · Aripiprazol Altedron, Aripiprazol Alter
- Romania · Aripiprazol Accord Healthcare, Aripiprazol Stada
- Sweden · Aregzilap, Aripiprazol Krka
- Slovenia · Aripiprazol Accord Healthcare, Aripiprazol Stada
- Slovakia · Aripiprazol Sandoz, Aripiprazol Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca9d818c-347f-41ae-b942-b244c1d9da1c GET /v1/drugs/ca9d818c-347f-41ae-b942-b244c1d9da1c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28795711000001102",
"desc": "Aripiprazole 30mg tablets (Actavis UK Ltd)",
"form": "Oral tablet",
"vpid": "42268411000001104",
"source": "dmd",
"vtm_id": "774636008",
"strength": "30 mg",
"substance": "Aripiprazole",
"ingredient": "Aripiprazole",
"supplier_code": "3875201000001104"
}See everything about aripiprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.